Non-inferiority randomised phase 3 trial comparing two radiation schedules (single vs. five fractions) in malignant spinal cord compression

被引：0
|
作者：
Pierre G. Thirion
Mary T. Dunne
Paul J. Kelly
Aileen Flavin
Joe M. O’Sullivan
Dayle Hacking
Wojciech Sasiadek
Cormac Small
Maeve M. Pomeroy
Joseph Martin
Orla McArdle
Imelda Parker
Lydia S. O’Sullivan
Aoife M. Shannon
Angela Clayton-Lea
Conor D. Collins
Michael R. Stevenson
Alberto Alvarez-Iglesias
John G. Armstrong
Michael Moriarty
机构：
[1] Cancer Trials Ireland (formerly All-Ireland Cooperative Oncology Research Group (ICORG)) and St Luke’s Radiation Oncology Network (SLRON),Statistics and Data Management Office for ICORG
[2] SLRON,undefined
[3] Cork University Hospital,undefined
[4] Belfast City Hospital,undefined
[5] UPMC Whitfield Cancer Centre,undefined
[6] University of Pittsburgh Medical Center,undefined
[7] Whitfield Cancer Centre,undefined
[8] Galway University Hospital,undefined
[9] Cancer Trials Ireland,undefined
[10] Clinical Research Support Centre,undefined
[11] The HRB Clinical Research Facility,undefined
来源：
British Journal of Cancer | 2020年 / 122卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1315 / 1323
页数：8
相关论文
共 40 条
  • [21] Conventional vs. Hypo-Fractionated, Radiotherapy for High-Risk Prostate Cancer (PCS5), Randomized, Non-Inferiority, Phase 3 Trial: Posthoc Analysis of IMRT vs. 3D-CRT Radiation Therapy Associated Toxicities
    Martinez, C.
    Karim, M.
    El-Misri, R.
    Kaldany, E.
    Nabid, A.
    Bettahar, R.
    Vincent, L. S.
    Martin, A. G.
    Jolicoeur, M.
    Yassa, M.
    Barkati, M.
    Bahoric, B.
    Archambault, R.
    Villeneuve, H.
    Mohiuddin, M.
    Niazi, T. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S25 - S26
  • [22] An international phase III randomized, non-inferiority trial comparing 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy for colon cancer: Compliance and safety of the phase III Japanese ACHIEVE trial.
    Eto, Tetsuya
    Kotaka, Masahito
    Manaka, Dai
    Hasegawa, Junichi
    Takagane, Akinori
    Nakamura, Masato
    Kato, Takeshi
    Munemoto, Yoshinori
    Nakamura, Fumitaka
    Bandou, Hiroyuki
    Taniguchi, Hiroki
    Gamoh, Makio
    Shiozawa, Manabu
    Yamanaka, Takeharu
    Mizushima, Tsunekazu
    Sakamoto, Junichi
    Saji, Shigetoyo
    Mori, Masaki
    Ohtsu, Atsushi
    Yoshino, Takayuki
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] Conventional vs. Hypofractionated, Radiotherapy for High-Risk Prostate Cancer: 7-Year Outcomes of the Randomized, Non-Inferiority, Phase 3 PCS5 Trial
    Niazi, T. M.
    Nabid, A.
    Malagon, T.
    Bettahar, R.
    Vincent, L. S.
    Martin, A. G.
    Jolicoeur, M.
    Yassa, M.
    Barkati, M.
    Igidbashian, L.
    Bahoric, B.
    Archambault, R.
    Villeneuve, H.
    Mohiuddin, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S3 - S3
  • [24] Simultaneous Integrated Boost vs. Conventional Radiotherapy for Patients with Limited -Stage Small Cell Lung Cancer: A Randomized, Non-Inferiority, Open-Label, Phase 3 Trial
    Zhan, T.
    Zhang, T.
    Deng, L.
    Wang, W.
    Wang, X.
    Wang, J.
    Liu, W., Jr.
    Qinfu, F.
    Zhai, Y.
    Mao, Z.
    Bi, N.
    Li, Y. X.
    Zhou, Z.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S61 - S61
  • [25] Updated results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer
    Iveson, T.
    Kerr, R.
    Saunders, M.
    Hollander, N.
    Tabernero, J.
    Haydon, A.
    Glimelius, B.
    Harkin, A.
    Scudder, C.
    Boyd, K.
    Waterston, A.
    Medley, L.
    Wilson, C.
    Ellis, R.
    Essapen, S.
    Dhadda, A.
    Harrison, M.
    Falk, S.
    Abdel-Raouf, S.
    Paul, J.
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] Two hypofractionated radiotherapy (RT) schedules (8 Gy x 2 vs. 8 Gy) in metastatic spinal cord compression (MSCC). Updating of an ongoing phase III randomized multicentretrial.
    Maranzano, E.
    Trippa, F.
    Rossi, R.
    Bellavita, R.
    Lupattelli, M.
    Marafioti, L.
    Pergolizzi, S.
    Mignogna, M.
    Cossa, S.
    Fusco, V.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S301 - S301
  • [27] EN BLOC VS. CONVENTIONAL TRANSURETHRAL RESECTION OF BLADDER TUMOR: TWO-YEAR ONCOLOGICAL FOLLOW-UP OF A SINGLE-CENTER PROSPECTIVE, RANDOMIZED, CONTROLLED, NON-INFERIORITY TRIAL
    Diana, Pietro
    Gallioli, Andrea
    Territo, Angelo
    Rodriguez-Faba, Oscar
    Maria Gaya, Josep
    Sanguedolce, Francesco
    Huguet, Jordi
    Parada, Ruben
    Sanz, Isabel
    Sanchez, Raul
    Farre, Alba
    Algaba, Ferran
    Palou, Joan
    Breda, Alberto
    JOURNAL OF UROLOGY, 2024, 211 (05): : E992 - E993
  • [28] Simultaneous Integrated Boost vs. Routine IMRT in LimitedStage Small-Cell Lung Cancer: An Open-Label, Non-Inferiority, Randomized, Phase 3 Trial-Interim Analysis
    Zhan, T.
    Zhou, Z.
    Zhang, T.
    Yan, W.
    Zhai, Y. R.
    Deng, L.
    Wang, W.
    Bi, N.
    Wang, J.
    Wang, X.
    Liu, W., Jr.
    Xiao, Z.
    Feng, Q.
    Chen, D.
    Lv, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E413 - E413
  • [29] Efficacy and cost-effectiveness of task-shared care for people with severe mental disorders in Ethiopia (TaSCS): a single-blind, randomised, controlled, phase 3 non-inferiority trial
    Hanlon, Charlotte
    Medhin, Girmay
    Dewey, Michael E.
    Prince, Martin
    Assefa, Esubalew
    Shibre, Teshome
    Ejigu, Dawit A.
    Negussie, Hanna
    Timothewos, Sewit
    Schneider, Marguerite
    Thornicroft, Graham
    Wissow, Lawrence
    Susser, Ezra
    Lund, Crick
    Fekadu, Abebaw
    Alem, Atalay
    LANCET PSYCHIATRY, 2022, 9 (01): : 59 - 71
  • [30] Final DFS results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer.
    Iveson, Timothy
    Kerr, Rachel
    Saunders, Mark P.
    Hollander, Niels Henrik
    Tabernero, Josep
    Haydon, Andrew Mark
    Glimelius, Bengt
    Harkin, Andrea
    Scudder, Claire
    Boyd, Kathleen
    Waterston, Ashita Marie
    Medley, Louise C.
    Wilson, Charles
    Ellis, Richard
    Essapen, Sharadah
    Dhadda, Amandeep Singh
    Harrison, Mark
    Falk, Stephen
    Raouf, Sherif
    Paul, James
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
1234